Added to YB: 2024-09-06
Pitch date: 2024-09-04
AVCR.V [neutral]
Avricore Health Inc.
-80.77%
current return
Author Info
Wolf of Oakville takes a magnifying glass to Canadian small cap stocks. Sign up for the newsletter.
Company Info
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers.
Market Cap
CAD 29.1M
Pitch Price
CAD 0.26
Price Target
N/A
Dividend
N/A
EV/EBITDA
54.47
P/E
-10.0K
EV/Sales
6.36
Sector
Health Care Technology
Category
growth
Avricore Health $AVCR.V FINS Review
AVCR.V (fair value, questions remain): Revenue +91% Q2, +84% YTD. Margins volatile (35.4% Q2, 41.7% LY). MC $28M, 7x sales. Profitable, but cash burn concerns. 20% SBC plan risk. Shoppers sole client, Rexall pilot slow. TAM promising if executed. Valuation fair. 3-star rating.
Read full article (3 min)